WallStreetZenWallStreetZen

NASDAQ: IBRX
Immunitybio Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Immunitybio earnings were -$409.1M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest IBRX earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$129.6M, up 119.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, IBRX reported annual earnings of -$413.6M, with -29.1% growth.

IBRX earnings history

Current Revenue
$31.2M
Current Earnings
-$409.1M
Current Profit Margin
-1,310.3%

IBRX Return on Equity

Insufficient data to display

IBRX undefined

Current Company
-109.4%
Current Industry
-2.5%
IBRX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when IBRX announces earnings.

IBRX undefined

Current Company
-103.57%
Current Industry
5.8%
IBRX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

IBRX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
IBRX-$240.81M-$409.10MN/A-$0.54
IMVT-$412.44M-$413.84MN/A-$2.73
AAPG-$32.47M-$55.46MN/A-$0.73
APGE-$202.64M-$205.39MN/A-$3.60
MLTX-$145.71M-$147.83MN/A-$2.30
View Top Biotech Stocks

Immunitybio Earnings Reports & History FAQ

What were Immunitybio's earnings last quarter?

On IBRX's earnings call on Invalid Date, Immunitybio (NASDAQ: IBRX) reported Q1 2025 earnings per share (EPS) of -$0.15, up 25% year over year. Total IBRX earnings for the quarter were -$129.65 million. In the same quarter last year, Immunitybio's earnings per share (EPS) was -$0.20.

If you're new to stock investing, here's how to buy Immunitybio stock.

Is Immunitybio profitable or losing money?

As of the last Immunitybio earnings report, Immunitybio is currently losing money. Immunitybio's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$409.10 million, a 31.93% decrease year over year.

What was IBRX's earnings growth in the past year?

As of Immunitybio's earnings date in Invalid Date, Immunitybio's earnings has grown year over year. IBRX earnings in the past year totalled -$409.10 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.